Olivier Biebuyck - Jul 25, 2022 Form 4/A - Amendment Insider Report for ESAB Corp (ESAB)

Role: President, EMEA
Signature: /s/ Curtis Jewell, Attorney-in-fact
Stock symbol: ESAB
Transactions as of: Jul 25, 2022
Transactions value $: -$18,559
Form type: 4/A - Amendment
Date filed: 7/29/2022, 06:00 PM
Date Of Original Report: Jul 27, 2022
Previous filing: May 16, 2022
Next filing: Aug 10, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ESAB	Common stock, par value $.001	Options Exercise		+911	+33.36%		3.64K	Jul 25, 2022	Direct	F1
transaction	ESAB	Common stock, par value $.001	Sale	-$18.6K	-456	-12.52%	$40.70	3.19K	Jul 27, 2022	Direct	F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ESAB	Restricted Stock Units	Options Exercise	$0	-911	-49.97%	$0.00	912	Jul 25, 2022	Common stock, par value $0.001	911		Direct	F1, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation.
F2	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units.
F3	The original Form 4, filed on July 27, 2022, is being amended by this Form 4 amendment to correct an administrative error, which misreported 308 shares of ESAB Corporation common stock were sold pursuant to the reporting person's Rule 10b5-1 trading plan at $41.224 per share when in fact 456 shares of ESAB Corporation common stock were sold pursuant to the reporting person's Rule 10b5-1 trading plan at $40.70 per share. As a result of this administrative error, the number of shares beneficially owned by the reporting person following the corrected transaction reflects a reduction in the number of shares reported as beneficially owned by the reporting person.
F4	These restricted stock units vest and become exercisable in two equal installments. 50% of the restricted stock units vested on July 25, 2022 and the remainder will vest on July 25, 2023.